Form 10-Q · Quarterly report
Steris 10-Q, filed Aug 7, 2026
- Filed
- CIK
- 0001757898
- Accession no.
- 0001628280-26-054830
Summary
Steris reported revenue of $1,492.7 million for the first three months of fiscal 2027, up 7.3% from $1,391.1 million a year earlier, while income from operations rose to $285.8 million from $246.0 million. Gross profit percentage was 45.8%, and cash flows from operations declined to $367.1 million from $420.0 million in the prior-year period.
Key points
- Steris completed three tuck-in acquisitions in the first three months of fiscal 2027 with total aggregate consideration of approximately $17.3 million.
- Cash flows from operations were $367.1 million and free cash flow was $279.6 million, compared with $420.0 million and $326.5 million in the first three months of fiscal 2026.
- Steris declared and paid cash dividends totaling $0.63 per ordinary share during the first three months of fiscal 2027.
- Debt-to-total capital ratio was 20.9% at June 30, 2026, compared with 21.3% at March 31, 2026.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Introduction In Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”), we explain the general financial condition and the results of operations for STERIS and its subsidiaries including: •what factors affect our business; •what our earnings and costs were in each period presented; •why those earnings and costs were different from prior periods; •where our earnings came from; •how this affects our overall financial condition; •what our expenditures for capital projects were; …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.